Valuation
- Market cap
- 1,000
- Revenue TTM
- $9,750,000
- Net income TTM
- $-39,650,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 250
- Avg volume
- 774
- Day's range
- $0.00 – $0.00
- Shares out
- 3,860,000
- Stochastic %K
- 67%
- Beta
- -1.26
- Analysts
- Strong Buy
- Price target
- $8.00
Company profile
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 650 870 1000
- Website
- https://www.calithera.com
- Address
- 343 Oyster Point Boulevard, Suite 200, South San Francisco, United States
Latest news
No headlines yet.
